A New Injectable Market

March 1, 2004

Raju Mantena, president and CEO of Orlando-based Icore, an injectable drug management company, has a strict warning for health plans: "Plans need to prepare themselves to slow the increase in injectable spending rather than trying to stop it, because it's not going to stop," he says.